Many of those had disastrous results (cardiovascular risk with stimulant-type agents, anal leaking of undigested fats with orlistat, to name a couple)
A major study of tirzapeptide, published in the New England Journal of Medicine in July 2022, a 72-week study in which trial participants with obesity received 5, 10 mg, or 15 mg of tirzepatide on a once-weekly basis provided substantial and sustained reductions in body weight. By week 72, the average participant receiving tirzapeptide had achieved a 15% body weight reduction
It means that in some cases, a healthcare provider may see diabetes as a bigger risk to the developing fetus than the medication, meaning treating a pregnant patient with Mounjaro could be safer than not treating them
We work hard to ensure our fees are competitive in the marketplace and fair for our patients
B.PatelM.ShengH.CalviC
So, if youre looking to tackle both A1C reduction and weight loss simultaneously, Semaglutide might be the superhero your diabetes management plan needs